Arnie
I just got one thing,
beside superbowl tickets and other frebees, Which by the way,are becoming a thing of the past. Doctors like to prescribe things that are safer,everything else being the same.
So if BOL is able in their promotion, to stress the safety factor, market share will be greater than 20 to 30% it might take time, and the better the sales force the quicker the time,
( Look into sales of tagamet and zantac, Zantac came in way later yet marketing was such it streesed smoe really minor safety issue, here it is major,. and they got the bulk of market share.)
I keep on posting it takes time to see what will happend, the projection are super conservative,.
As for the price moving with the same news.
The news was not the same the big question was broad labeling.
Also with most companies there is a pop in price when FDA comes with approval even after approvable letter was done so before.
It is a great safe way to make money.
So if Any one Knows of other Pharamaceutical that got approvable letter and are waiting for final approval.
It will be great if you can share the info so we all can be great investors. |
